Clinical Trials Browser

Phase 1 × Gastrointestinal Stromal Tumors × Ipilimumab × Clear all

NCT01643278 2017-01-10

Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic

Phase 1 Completed

GastrointestinalSarcoma

Sarcoma, Gastrointestinal Stromal Tumors